Unknown

Dataset Information

0

Dihydrothiazolopyridone derivatives as a novel family of positive allosteric modulators of the metabotropic glutamate 5 (mGlu5) receptor.

ABSTRACT: Starting from a singleton chromanone high throughput screening (HTS) hit, we describe a focused medicinal chemistry optimization effort leading to the identification of a novel series of phenoxymethyl-dihydrothiazolopyridone derivatives as selective positive allosteric modulators (PAMs) of the metabotropic glutamate 5 (mGlu5) receptor. These dihydrothiazolopyridones potentiate receptor responses in recombinant systems. In vitro and in vivo drug metabolism and pharmacokinetic (DMPK) evaluation allowed us to select compound 16a for its assessment in a preclinical animal screen of possible antipsychotic activity. 16a was able to reverse amphetamine-induced hyperlocomotion in rats in a dose-dependent manner without showing any significant motor impairment or overt neurological side effects at comparable doses. Evolution of our medicinal chemistry program, structure activity, and properties relationships (SAR and SPR) analysis as well as a detailed profile for optimized mGlu5 receptor PAM 16a are described.

SUBMITTER: Bartolome-Nebreda JM 

PROVIDER: S-EPMC3924858 | biostudies-literature | 2013 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Starting from a singleton chromanone high throughput screening (HTS) hit, we describe a focused medicinal chemistry optimization effort leading to the identification of a novel series of phenoxymethyl-dihydrothiazolopyridone derivatives as selective positive allosteric modulators (PAMs) of the metabotropic glutamate 5 (mGlu5) receptor. These dihydrothiazolopyridones potentiate receptor responses in recombinant systems. In vitro and in vivo drug metabolism and pharmacokinetic (DMPK) evaluation al  ...[more]

Similar Datasets

Unknown Cyclopropyl-containing positive allosteric modulators of metabotropic glutamate receptor subtype 5.
| S-EPMC4690453 | biostudies-literature
Unknown Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.
| S-EPMC2574552 | biostudies-literature
Unknown Acyl dihydropyrazolo[1,5-a]pyrimidinones as metabotropic glutamate receptor 5 positive allosteric modulators.
| S-EPMC4634704 | biostudies-literature
Unknown A novel metabotropic glutamate receptor 5 positive allosteric modulator acts at a unique site and confers stimulus bias to mGlu5 signaling.
| S-EPMC3608436 | biostudies-literature
Unknown Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5).
| S-EPMC3369763 | biostudies-other
Unknown Tetrahydronaphthyridine and dihydronaphthyridinone ethers as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu?).
| S-EPMC4096224 | biostudies-literature
Unknown Positive allosteric modulators of metabotropic glutamate 1 receptor: characterization, mechanism of action, and binding site.
| S-EPMC60883 | biostudies-literature
Unknown Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2.
| S-EPMC9299836 | biostudies-literature
Unknown Metabotropic glutamate receptor 5 negative allosteric modulators as novel tools for in vivo investigation.
| S-EPMC3424002 | biostudies-literature
Unknown Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of Huntington's disease.
| S-EPMC3687670 | biostudies-literature